Related Articles
Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic target
miR‑494 inhibits cancer‑initiating cell phenotypes and reverses resistance to lapatinib by downregulating FGFR2 in HER2‑positive gastric cancer
Cancer genomics and genetics of FGFR2 (Review)
FGFR2 and WDR11 are neighboring oncogene and tumor suppressor gene on human chromosome 10q26
FGFR2-related pathogenesis and FGFR2-targeted therapeutics (Review)